This Year's Theme, "Harmony in Interdisciplinary Care: Blending Expertise," Celebrates True Collaboration in Patient-Centered Dentistry
KEY BISCAYNE, Fla., July 30, 2025 /PRNewswire/ -- The Pankey...
Plan Confirmation and Sale Approval Court Date Expected in Early September
GAINESVILLE, Fla., July 24, 2025 /PRNewswire/ -- Exactech, a global medical technology leader, has filed...
DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025...
NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...
NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...
Jacksonville, FL, July 14, 2025 (GLOBE NEWSWIRE) -- ASAP Dental Care, a leading provider of dental implants in Jacksonville and across Northeast Florida, has achieved a significant milestone in its surgical operations and patient care services, having successfully placed more than 9600 implants to date. The figure reflects cumulative procedures completed over the past years and includes both single-tooth and full-arch restorations.
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs
Acquisition expected to be neutral to adjusted earnings...
BIEL, Switzerland and BERN, Switzerland, July 11, 2025 /PRNewswire/ -- As product requirements evolve, engineers and designers search for solutions that enable greater integration,...
PUNE, India, July 9, 2025 /PRNewswire/ -- According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2...
PUNE, India, July 9, 2025 /PRNewswire/ -- According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2...
- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins - Series B round in planning to support pivotal U.S. trial - New CEO appointment signals next phase of growth and expansion